Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

5.360 +0.060 (+1.13%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	576,535
Open	5.330
Bid (Size)	5.210 (100)
Ask (Size)	5.400 (500)
Prev. Close	5.300
Today's Range	5.300 - 5.475
52wk Range	3.809 - 5.700
Shares Outstanding	55,638,166
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review ↗

November 28, 2025

Via Stocktwits

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat ↗

November 20, 2025

Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets.

Via Benzinga

Performance

YTD	+11.2%	+11.2%
1 Month	+24.1%	+24.1%
3 Month	+13.8%	+13.8%
6 Month	+24.7%	+24.7%
1 Year	+4.1%	+4.1%

More News

Which stocks are moving on Tuesday? ↗

November 18, 2025

Via Chartmill

Top movers in Tuesday's session ↗

November 18, 2025

Via Chartmill

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark ↗

August 18, 2025

Via Stocktwits

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

A Glimpse of Vanda Pharma's Earnings Potential ↗

May 06, 2025

Via Benzinga

Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients ↗

November 18, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 18, 2025

Via Chartmill

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗

November 05, 2025

Via Benzinga

This Trex Company Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday ↗

November 05, 2025

Via Benzinga

The Analyst Verdict: Vanda Pharma In The Eyes Of 5 Experts ↗

February 18, 2025

Via Benzinga

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts ↗

January 28, 2025

Via Benzinga

VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Reports Q3 2025 Earnings Miss on Revenue, Beat on EPS ↗

October 29, 2025

Via Chartmill

Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock ↗

October 27, 2025

Via Benzinga

AnaptysBio Charts Path To Split Into Two Public Companies By 2026 ↗

September 30, 2025

Via Benzinga

Retail Buzz Builds As Vanda Urges FDA Chief To Revisit Hetlioz Generics Decision — Alleges “Bias Toward Approvals” ↗

August 21, 2025

Via Stocktwits

Vanda (VNDA) Q2 Revenue Rises 4% ↗

August 01, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 23, 2025

Via Benzinga

Forecasting The Future: 5 Analyst Projections For Vanda Pharmaceuticals ↗

April 01, 2025

Via Benzinga

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

February 03, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate ↗

January 16, 2025

Via Benzinga

Frequently Asked Questions

Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?

Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.

What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?

Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?

The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market

What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?

The current price of Vanda Pharmaceuticals Inc. - Common Stock is 5.360

When was Vanda Pharmaceuticals Inc. - Common Stock last traded?

The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 11/28/25 01:00 PM ET

What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?

The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 298.22M

How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?

Vanda Pharmaceuticals Inc. - Common Stock has 298M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.